Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 50 | 2 | 56 | +8 |
| Shares | 2.28M | 5.83K | 2.30M | +24.4K (+1.1%) |
| Value | $8.16M | $20.4K | $5.99M | −$2.15M (−26.4%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rathbone Brothers plc | 289,803 | $756.4K | 0.01% |
| Dimensional Fund Advisors LP | 27,285 | $71.2K | 0.00% |
| Virtu Financial LLC | 17,388 | $45.0K | 0.00% |
| Algert Global LLC | 14,680 | $38.3K | 0.00% |
| N.E.W. Advisory Services LLC | 12,960 | $33.8K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 11,900 | $31.1K | 0.00% |
| Group One Trading, L.P. | 10,495 | $27.4K | 0.00% |
| Invesco Ltd. | 10,094 | $26.3K | 0.00% |
| Qube Research & Technologies Ltd | 9,890 | $25.8K | 0.00% |
| Royal Bank of Canada | 5,273 | $14.0K | 0.00% |
| Quantbot Technologies LP | 931 | $2.43K | 0.00% |
| FMR LLC | 900 | $2.35K | 0.00% |
| Federated Hermes, Inc. | 122 | $318 | 0.00% |
| BNP Paribas Arbitrage, SA | 13 | $34 | 0.00% |
Sold out (6)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Millennium Management LLC | 78,620 | $281.5K |
| Samson Rock Capital LLP | 36,856 | $131.9K |
| Acadian Asset Management LLC | 31,736 | $113.0K |
| Schonfeld Strategic Advisors LLC | 30,300 | $108.5K |
| Northern Trust Corp | 11,569 | $41.4K |
| HighTower Advisors, LLC | 10,500 | $39.0K |
Not filed for Q3 2023 yet (2)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Endurance Wealth Management, Inc. | 5,700 | $20.0K |
| Coastal Capital Group, Inc. | 125 | $448 |